Scutellarin suppresses cartilage destruction in osteoarthritis mouse model by inhibiting the NF-κB and PI3K/AKT signaling pathways

Wenhan Wang,Jiayi Li,Feng Li,Jiangfan Peng,Mingyang Xu,Yangtao Shangguan,Yuanming Li,Yunpeng Zhao,Cheng Qiu,Ruize Qu,Weiwei Li,Cuijuan Zhang,Tingguo Zhang
DOI: https://doi.org/10.1016/j.intimp.2019.105928
IF: 5.714
2019-12-01
International Immunopharmacology
Abstract:<p>Osteoarthritis (OA), a common and severe disease, is predominantly characterized by cartilage destruction, which results in the degeneration of joint surfaces. Nowadays, it is accepted that TNFα plays a critical role in OA. Scutellarin, the main bioactive flavonoid glycoside extracted form <em>Erigeron breviscapus</em>, has been reported to exert positive effects on anti-inflammatory reactions. However, the effect of scutellarin in OA is still unknown. In this study, we isolated and cultured primary murine chondrocytes, stimulating TNF-α, in the presence or absence of scutellarin treatment. We found that the inflammatory response stimulated by TNF-α was significantly inhibited by the addition of scutellarin. Moreover, we established OA mouse models induced by surgery. In this mouse model, both inflammatory reaction and cartilage degeneration were markedly inhibited by oral administration of scutellarin. Furthermore, the cellular mechanism underlying the protective effect of scutellarin in OA was clearly associated with the NF-κB and PI3K/AKT signaling pathways. Collectively, this study proposes scutellarin as a potential therapeutic to treat joint degenerative diseases, including OA.</p>
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?